Research

Hormonal

Targeting senescent cells (via genetic clearance or JAK1/2 inhibition) in aged individuals restores adipose tissue function, increases insulin sensitivity, and prevents age-related fat loss by suppressing the secretion of activin A.

This research suggests that age-related fat loss and insulin resistance are driven by 'zombie' (senescent) cells releasing harmful signals like activin A. In animal models, blocking these signals using a specific drug (ruxolitinib) preserved fat mass and improved metabolic health. While promising, this is currently an experimental application of an existing drug in animals, not a standard human therapy.

GoodSupportsHIGH confidence
Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.
Ming Xu et al. · eLife · 2015

Why this rating

Strong evidence from multiple models (human cell culture, progeroid mice, naturally aged mice) with consistent results, though limited to animal models for in vivo claims.

Source

Targeting senescent cells enhances adipogenesis and metabolic function in old age

Ming Xu et al. · eLife · 2015

DOI 10.7554/elife.12997

mechanism_onlyCited 589×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →